Clinical observation of 6 severe COVID-19 patients treated with plasma exchange or tocilizumab / 浙江大学学报·医学版
Journal of Zhejiang University. Medical sciences
;
(6): 227-231, 2020.
Artículo
en Chino
| WPRIM
| ID: wpr-828548
ABSTRACT
OBJECTIVE@#To observe the clinical effect of plasma exchange and tocilizumab in treatment of patients with severe coronavirus disease 2019 (COVID-19).@*METHODS@#Six patients with severe COVID-19 admitted in First Affiliated Hospital of Bengbu Medical College from January 25 to February 25, 2020. Three patients were treated with plasma exchange and three patients were treated with tocilizumab. The effect on excessive inflammatory reaction of plasma exchange and tocilizumab was observed.@*RESULTS@#The C-reactive protein (CRP) and IL-6 levels were significantly decreased and the lymphocyte and prothrombin time were improved in 3 patients after treatment with plasma exchange; while inflammation level was not significantly decreased, and lymphocyte and prothrombin time did not improve in 3 patients treated with tocilizumab.@*CONCLUSIONS@#For severe COVID-19 patients with strong inflammatory reaction, plasma exchange may be preferred.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Intercambio Plasmático
/
Neumonía Viral
/
Tiempo de Protrombina
/
Estándares de Referencia
/
Terapéutica
/
Sangre
/
Resultado del Tratamiento
/
Infecciones por Coronavirus
/
Alergia e Inmunología
/
Pandemias
Límite:
Humanos
Idioma:
Chino
Revista:
Journal of Zhejiang University. Medical sciences
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS